BIOVIE INC BIVI
ASignal's systematic analysis rates BIVI as Bearish.
Reflects the latest available analysis · analyzed Nov 14, 2026
The case on BIVI
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong cash position with $8.98M total cash
- Low debt-to-equity ratio of 0.03x
- Current ratio of 3.59x indicating solid short-term financial health
- Financial health score of 0.9 suggests low near-term solvency risk
- Negative return on equity (-150.76%) and return on assets (-79.06%)
- Negative operating cash flow ($-19.02M) and free cash flow ($-11.12M)
- Price below both SMA20 and SMA50, indicating strong downtrend
- Negative MACD histogram and declining momentum
- No Reddit mentions, suggesting lack of retail interest or visibility
- Negative EV/EBITDA of -0.06x and unprofitable margins
See the full verdict on BIVI
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes BIVI
Most investors never get a second opinion, let alone several. ASignal runs BIVI past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.